In our cohort, a high AST/ALT ratio was as predictive of intravesical recurrence as traditional risk factors like positive margin status or synchronous bladder tumor, suggesting it could be used as part of a risk-stratified follow-up schedule. The gene discussed is GPT; the disease is urinary bladder neoplasm.